About
TEGA Therapeutics develops glycoscience-based therapies focusing on recombinant heparan sulfate production and enzyme replacement therapies to treat genetic diseases involving heparan sulfate degradation.
Explore TEGA Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.